4D Molecular Therapeutics (FDMT) PT Raised to $17 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Mani Foroohar raised the price target on 4D Molecular Therapeutics (NASDAQ: FDMT) to $17.00 (from $16.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
